Northwestern Mutual Wealth Management’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
RA
Northwestern Mutual Wealth Management's FLNA Position: Q4 2024 in Review
Northwestern Mutual Wealth Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 12 shares — an estimated $353 sold.
Northwestern Mutual Wealth Management first reported a position in FLNA in Q1 2022 and held it in 5 quarters. The position peaked at $5K in Q1 2022. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.
- Northwestern Mutual Wealth Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 12 Filana Therapeutics shares in Q4 2024, an estimated $353.
- Northwestern Mutual Wealth Management first reported a position in Filana Therapeutics in Q1 2022 and held it in 5 quarters.
- Northwestern Mutual Wealth Management's Filana Therapeutics position peaked at $5K in Q1 2022.
- 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.
Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.